ARYA Sciences Acquisition Corp IV

NasdaqCM:ARYD Stock Report

Market Cap: US$50.0m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

ARYA Sciences Acquisition Corp IV Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Adam Stone

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.6yrs
CEO ownershipn/a
Management average tenure3.6yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

Seeking Alpha • Oct 06

Amicus Therapeutics Carves Out Gene Therapy Portfolio, Reduces Upside Optionality

Amicus Therapeutics announced the formation of Caritas Therapeutics, consisting of Amicus' gene therapy portfolio. Amicus' stake will go from 100% to 36%, reducing the upside optionality of the gene therapy portfolio. The upside of the deal for Amicus is reduced costs and a clear path to profitability which could happen as soon as 2023. Amicus will now fully focus on Fabry and Pompe disease with Galafold and AT-GAA, and through retained 50% ownership of gene therapy programs for the two diseases. Amicus looks undervalued but without meaningful catalysts in the following quarters and with risks surrounding AT-GAA and the likely lack of investor recognition for this asset until it proves itself on the market.

CEO

Adam Stone (44 yo)

3.6yrs
Tenure

Mr. Adam Leo Stone is Chief Investment Officer & Head of Research of Perceptive Advisors LLC. He joined the Perceptive Advisors LLC in 2006. He serves as CEO & Director at Perceptive Capital Solutions Corp...

Leadership Team

NamePositionTenureCompensationOwnership
Adam Stone
CEO & Director3.6yrsno datano data
Michael Altman
CFO & Director3.6yrsno datano data
Konstantin Poukalov
Chief Business Officer3.6yrsno datano data
3.6yrs
Average Tenure
42yo
Average Age

Experienced Management: ARYD's management team is considered experienced (3.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Adam Stone
CEO & Director3.6yrsno datano data
Michael Altman
CFO & Director3.6yrsno datano data
Leslie Trigg
Independent Director3.5yrsno data0.40%
$ 199.2k
Joseph Edelman
Independent Chairman of the Board3.6yrsno datano data
Todd Wider
Independent Director3.6yrsno data0.40%
$ 199.2k
Michael Henderson
Independent Director3.5yrsno data0.40%
$ 199.2k
3.6yrs
Average Tenure
48.5yo
Average Age

Experienced Board: ARYD's board of directors are considered experienced (3.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/08/01 12:35
End of Day Share Price 2024/07/31 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ARYA Sciences Acquisition Corp IV is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.